Heart Failure Congestive: Clinical Trials

5 trials for Heart Failure Congestive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 2 Not applicable, 2 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1
Phase 42Recruiting 1, Withdrawn 1
Phase 21Terminated 1

Follow Heart Failure Congestive: new trials by email Literature Review of Heart Failure Congestive trials Research Report on Heart Failure Congestive

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Implantation of the V-Wave Interatrial shunt, Sham (no implant) - Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Not applicableNot yet recruitingV-Wave Ltd2502026-09-302026-07-10
VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure
Bumetanide, intranasal 4mg - Heart Failure Congestive
Phase 4WithdrawnPrisma Health-Upstate2026-01-212026-01-29
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
Losartan 50 mg, Placebo - Heart Valve Diseases, Left Ventricle Remodeling
Phase 4RecruitingVitor Emer Egypto Rosa602025-07-012025-08-01
AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure
MYDICAR-single intracoronary infusion, Placebo; single intracoronary infusion - Heart Failure Congestive, Ischemic Cardiomyopathy
Phase 2TerminatedAssistance Publique - Hôpitaux de Paris102013-12-012017-08-29
Effect of omega3 on Congestive Heart Failure
placebo, omga3 - Heart Failure Congestive
Not applicableCompletedShiraz University of Medical Sciences702008-10-012010-10-25

Narrower conditions

Heart Failure (5)  ·  Aortic Valve Insufficiency (1)  ·  Cardiomyopathies (1)  ·  Heart Failure, Systolic (1)  ·  Heart Valve Diseases (1)  ·  Ventricular Remodeling (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Heart Diseases (5)  ·  Aortic Valve Disease (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Bumetanide (1)  ·  Losartan (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Prisma Health-Upstate (1)  ·  Shiraz University of Medical Sciences (1)  ·  V-Wave Ltd (1)  ·  Vitor Emer Egypto Rosa (1)

Countries

Brazil (1)  ·  France (1)  ·  Iran (1)  ·  United States (1)

Top investigators

Gregg W. Stone, MD (1)  ·  Jason L Guichard, MD, PhD (1)  ·  Joann Lindenfeld, MD (1)  ·  Michael Zile, MD (1)  ·  Vitor E. E. Rosa, MD, PhD (1)  ·  William T Abraham, MD (1)

Results publications

PMID 24023466, PMID 28393439

NIH funding

2023 (1)